Basic information
Biomarker: MMP9
Histology type: endometrial clear cell carcinoma
Cohort characteristics
Country: UK
Study type: prospective case-control study
Followed up time :
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
100 | EC | 50 | controls | 50 |
Sample information
Conclusion: A patient-friendly, urine-based test could offer a non-invasive endometrial cancer detection tool in symptomatic women. Validation in a larger independent cohort is warranted.
Sample type : urine
Sample method: mass spectrometric analysis
Disease information
Related information
Funtion Uniprot: Matrix metalloproteinase that plays an essential role in local proteolysis of the extracellular matrix and in leukocyte migration (PubMed:2551898, PubMed:1480034, PubMed:12879005). Could play a role in bone osteoclastic resorption (By similarity). Cleaves KiSS1 at a Gly-|-Leu bond (PubMed:12879005). Cleaves NINJ1 to generate the Secreted ninjurin-1 form (PubMed:32883094). Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments (PubMed:1480034). Degrades fibronectin but not laminin or Pz-peptide
UniProt ID: P14780
UniProt Link: https://www.uniprot.org/uniprotkb/P14780/entry
Biological function from UniProt: #Collagen degradation
Molecular function from UniProt:
Tissue specificity from UniProt: Detected in neutrophils (at protein level) (PubMed:7683678). Produced by normal alveolar macrophages and granulocytes
Subcellular UniProt: #Extracellular matrix #Secreted
Miscellaneous: In the arthritis patient this enzyme might contribute to the pathogenesis of joint destruction and might constitute a useful marker of disease status.
Catalytic activity: Cleavage of gelatin types I and V and collagen types IV and V.
Activity regulation: Inhibited by histatin-3 1/24 (histatin-5). Inhibited by ECM1.
Recommended name: Matrix metalloproteinase-9
Gene name from HGNC: MMP9 (CLG4B)
HPA class: Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Human disease related genes Plasma proteins Potential drug targets
AlphaFold DB: P14780
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P14780
Induction: Activated by 4-aminophenylmercuric acetate and phorbol ester. Up-regulated by ARHGEF4, SPATA13 and APC via the JNK signaling pathway in colorectal tumor cells. (Microbial infection) Expression induced by M.bovis MPB83 (at protein level) (PubMed:20800577).
HPA link: https://www.proteinatlas.org/ENSG00000100985-MMP9
Tissue specificity RNA from HPA: Group enriched (bone marrow, lymphoid tissue)
Tissue expression from HPA: Lymphoid tissue & Bone marrow - Innate immune response (mainly)
Single cell type specificity Group enriched (Langerhans cells, Macrophages, Hofbauer cells)
Immune cell specificity: Immune cell enriched (neutrophil)
Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable), endometrial cancer (favorable) and liver cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000100985-MMP9/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000100985-MMP9/pathology/endometrial+cancer